Optimizing Pathways in Cancer Care

Our exosome technology precisely maps cancer's presence and guides optimal treatment paths with 24-hour results.

The Exosome Revolution in Cancer Care

Our proprietary technology analyzes RNA biomarkers protected within naturally occurring exosomes, enabling detection at concentrations 10,000 times lower than conventional methods.

Explore our Technology

>97%

Sensitivity across all cancer stages in our validation studies, compared to just 22% for Stage I detection with conventional methods, enabling treatment when it matters most.

24h

Turnaround time from sample receipt to complete results, dramatically reducing the typical 7-14 day waiting period and enabling faster clinical decisions.

10,000x

Greater sensitivity than conventional PCR or NGS methods, with the ability to detect variant allele frequencies as low as 0.001%, identifying cancer signals before they're visible on imaging.

Pioneering Applications

Our first technology applications address critical needs in the cancer care continuum.

Early Cancer Detection When It Matters Most

ExoDiscovery Detect® enables ultra-sensitive screening for high-risk individuals, identifying cancer signals before they're visible on conventional tests. Our first application focuses on pancreatic cancer detection in patients with hereditary risk factors.

Precision Treatment Guidance and Monitoring

ExoDiscovery Monitor® provides oncologists with real-time insights into treatment effectiveness and early resistance detection. Our lung cancer application tracks a growing number of mutations with unprecedented sensitivity, guiding critical therapy decisions.

Groundbreaking Research Partnerships

We're advancing cancer care through strategic collaborations with leading institutions in the US. Our expanding biomarker panel will soon include additional mutations and cancer types, creating a comprehensive platform for personalized medicine.

ExoDiscovery collaborates with world-class medical centers and research institutions.

Discover the Future of Cancer Diagnostics

ExoDiscovery's revolutionary technology provides unprecedented insights into cancer at the molecular level—enabling earlier detection and more precise treatment monitoring with 24-hour results.

Our technology is currently being evaluated by leading oncology specialists at major medical centers, with clinical adoption beginning in 2025.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.